INCY
INCYTE CORP
NASDAQ · Healthcare · Biotechnology · US
$125.31
−1.81%Margins
Gross margin
92.6%
EBITDA margin
35.1%
EBIT margin
31.6%
Net margin
27.7%
FCF margin
33.0%
25.4%
Return on equity
20.5%
Return on assets
28.8%
Return on invested capital
0.77x
Asset turnover
$2.0B
Cash from operations
$22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026